Form 4 for MEDS DataMeds AI, Inc.
Accepted 2026-06-25 16:59:18 ET · period of report 2026-06-22 · accession 0001493152-26-030154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 16:59 | 2026-06-22 | MEDS | AJJARAPU SURENDRA K | Dir | X - OptEx | $0.005 | +100.0K | 257.6K | +63% | +$500 |
| D | 2026-06-25 16:59 | 2026-06-22 | MEDS | AJJARAPU SURENDRA K | Dir | X - OptEx | $0.00 | +100.0K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-22 | X | A | 100,000 | $0.005 | 257,645 | D | — | — | (F1) Represents the conversion of warrants (the "Warrants") issued to the Reporting Person on 3/31/2026 in lieu of cash compensation due to the Reporting Person. (F2) Reflects the aggregate amount of Common Stock held by the Reporting Person following the Issuer's reverse stock split, effective May 26, 2026, as well as the Common Stock issued pursuant to the conversion of the Warrants. |
| 2 | Derivative | Warrant | 2026-06-22 | X | A | 100,000 | $0.00 | 0 | D | $0.005 · 2026-03-31 to 2031-03-31 | 100,000 Common Stock |